Transfusion Surveillance in Anaesthesia

Biological Transfusion Efficiency Registry Transfusion Surveillance in Anaesthesia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06403163

Acronym

STAR

Enrollment

50000

Registered

2024-05-07

Start date

2022-09-01

Completion date

2030-12-31

Last updated

2025-09-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Anesthesia; Shock, Blood Coagulation Disorder, Blood Loss, Fresh Blood Stool, Side Effect, Transfusion Reaction, Transfusion Related Complication

Keywords

transfusion, monitoring, emergency situation, shock, fresh frozen plasma

Brief summary

Detailed description

the aim of this register is to collect exhaustively the different data available surrounding a transfusion act in the context of an active haemorrhage. The aim is to allow different modelling and analysis related to emergency transfusion. Patients will be informed at the time of the anaesthesia consultation about the inclusion in the registry. The data will be collected from the patients' files by the investigators of the centre without modifying their management. The data collection period will not exceed the period of acute management.

Interventions

PROCEDURETransfusion

Transfusion of an hemostatic product

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* all patients who have received an hemostasis product

Exclusion criteria

* patient who refused to consent to data analysis and study participation

Design outcomes

Primary

Measure	Time frame	Description
Hemostatic evolution through transfusion event	12 hours	evolution of APTT (seconds)
ROTEM measures evolution through transfusion event	12 hours	evolution of APTEMCT (seconds)
Haematologic measures evolution through transfusion event	12 hours	evolution of hemoglobin (g/dL)
ionic measures evolution through transfusion event	12 hours	evolution of lactate (mmol/L)

Secondary

Measure	Time frame	Description
Mortality at one month	one month	Mortality at one month

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026